Stocktoria

Burning Rock Biotech Ltd BNR

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2020-06-12

Burning Rock Biotech Ltd financials (annual)

Revenue
$381.7M $65.9M $79.7M $81.7M $75.7M $70.7M $77.2M 2019202020212022202320242025
Net income
-$169.2M -$62.4M -$125.0M -$140.8M -$92.1M -$47.5M -$7.9M 2019202020212022202320242025
Free cash flow
-$271.0M -$20.5M -$107.1M -$75.2M -$37.2M -$13.4M -$4.8M 2019202020212022202320242025

Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue$77.2M$70.7M$75.7M$81.7M$79.7M$65.9M$381.7M
Gross profit$57.6M$49.6M$51.2M$55.1M$57.1M$48.1M$273.3M
R&D expense$23.8M$31.8M$48.9M$61.2M$57.7M$40.5M$156.9M
Operating income-$7.8M-$49.0M-$94.3M-$142.1M-$125.1M-$63.2M-$169.1M
Interest expense$241,000$102,000$9.0M
Income tax$223,000$806,000$336,000$288,000$141,000$0$0
Net income-$7.9M-$47.5M-$92.1M-$140.8M-$125.0M-$62.4M-$169.2M
Operating cash flow-$4.1M-$12.6M-$36.0M-$66.2M-$75.0M-$11.3M-$228.0M
Free cash flow-$4.8M-$13.4M-$37.2M-$75.2M-$107.1M-$20.5M-$271.0M
Cash & equivalents$68.4M$71.2M$86.6M$131.3M$224.6M$290.5M$94.2M
Inventory$6.9M$8.6M$9.7M$18.9M$19.3M$10.4M$58.1M
Total assets$117.3M$121.3M$146.5M$230.2M$357.6M$408.1M$847.6M
Total liabilities$40.8M$41.7M$38.3M$62.2M$68.0M$37.1M$212.0M
Shareholders' equity$76.5M$79.6M$108.2M$167.9M$289.6M$371.0M-$891.5M

Growth · year-over-year · Revenue CAGR -23.4%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue growth+9.2%-6.6%-7.3%+2.5%+21.0%-82.7%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.